National prevalence of heart failure in type 2 diabetes patients derived from the National eHealth System and their access to treatment with SGLT2 inhibitors or GLP-1 Receptor Agonists

Date Issued

2019-10

Author(s)

Mihajlovska Dzulijana

Smokovski Ivica

Kocinski Goran

File(s)

Name

K. kardio 2019, K8.jpg

Size

3.25 MB

Format

JPEG

Checksum

(MD5):b9a9687fe057c14360989bfea24261d2